This interactive module equips clinicians with practical strategies to apply precision oncology in breast cancer care, focusing on biomarker-driven treatment decisions across various clinical scenarios.
Course Accreditations
Course Summary
| Events Starts | Events Ends |
|---|---|
| 1/1/2025 | 12/31/2025 |
Faculty
James C. Dickerson (MD, MS)
Dr. Dickerson is a breast medical oncologist at the Stanford University School of Medicine. His research studies how health policy can improve health equity and eliminate cancer disparities. He has both a domestic and global arm of his research team. His global oncology research leverages long-standing collaborations in Nigeria and Belize to understand how to build financially sustainable and equitable cancer care in low and middle income countries.
Disclosure
Financial relationships No, I have not had a financial relationship with an ineligible company within the past 24 months.
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
Target Audience
- Interpret molecular and genomic test results to guide personalized breast cancer therapies.
- Select appropriate targeted treatments based on tumor subtype and patient-specific factors.
- Integrate current clinical trial evidence into individualized treatment planning
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: